Bio-Techne (TECH) Net Income towards Common Stockholders (2009 - 2026)

Bio-Techne's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $51.0 million for Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 125.99% year-over-year to $51.0 million in Q1 2026; TTM through Mar 2026 was $22.7 million, a 71.78% decrease from a year earlier, with the FY2025 full-year figure at -$13.4 million, down 111.46% from the prior year.
• Net Income towards Common Stockholders rose to $51.0 million in Q1 2026 per TECH's latest filing, from $38.0 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $89.7 million in Q3 2022 and bottomed at -$104.5 million in Q2 2025.
• The 5-year median for Net Income towards Common Stockholders is $49.1 million (2024), against an average of $38.0 million.
• Across the five-year window, Net Income towards Common Stockholders jumped 615.95% in 2022 and tumbled 899.35% in 2025, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at $50.0 million in 2022, then tumbled by 45.08% to $27.5 million in 2023, then advanced by 27.03% to $34.9 million in 2024, then advanced by 8.94% to $38.0 million in 2025, then jumped by 34.3% to $51.0 million in 2026.
• Per Business Quant, the three latest TECH Net Income towards Common Stockholders figures stand at $51.0 million (Q1 2026), $38.0 million (Q4 2025), and $38.2 million (Q3 2025).